Regulatory roundup

More healthcare-related regulatory news for plan sponsors, including links to detailed information.

Medicare Parts A and B cost-of-living adjustments for 2019 published
The Centers for Medicare and Medicaid Services (CMS) has issued the cost-of-living adjustments (COLAs) applicable to components in the Medicare program for 2019.

To view the rates, click here.

Bills prohibiting pharmacy “gag” clauses signed into law
President Trump signed the Patient Right to Know Drug Prices Act and the Know the Lowest Price Act of 2018 into law. The first prohibits health insurers and pharmacy benefit managers from limiting a pharmacy’s ability to discuss cheaper drug options with consumers. These “gag” clauses prevent pharmacists from telling group health plan enrollees, and individual drug plan enrollees, whether the retail price of a drug would be cheaper than the enrollees’ copay amount.

This second prohibits a prescription drug plan under Medicare or Medicare Advantage from restricting a pharmacy from informing an enrollee of any difference between the price, copayment, or coinsurance of a drug under the plan and a lower price of the drug without health insurance coverage.

HHS releases annual civil monetary penalties inflation adjustment
The U.S. Department of Health and Human Services (HHS) is updating its regulations to reflect required annual inflation-related increases to the civil monetary penalties in its regulations, pursuant to the Federal Civil Penalties Inflation Adjustment Act Improvements Act of 2015.

For more information, click here.